443 related articles for article (PubMed ID: 12800245)
1. Celecoxib inhibits proliferation and induces apoptosis via prostaglandin E2 pathway in human cholangiocarcinoma cell lines.
Wu GS; Zou SQ; Liu ZR; Tang ZH; Wang JH
World J Gastroenterol; 2003 Jun; 9(6):1302-6. PubMed ID: 12800245
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 promotes human cholangiocarcinoma growth: evidence for cyclooxygenase-2-independent mechanism in celecoxib-mediated induction of p21waf1/cip1 and p27kip1 and cell cycle arrest.
Han C; Leng J; Demetris AJ; Wu T
Cancer Res; 2004 Feb; 64(4):1369-76. PubMed ID: 14973068
[TBL] [Abstract][Full Text] [Related]
3. Proliferative activity of bile from congenital choledochal cyst patients.
Wu GS; Zou SQ; Luo XW; Wu JH; Liu ZR
World J Gastroenterol; 2003 Jan; 9(1):184-7. PubMed ID: 12508379
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.
Leahy KM; Ornberg RL; Wang Y; Zweifel BS; Koki AT; Masferrer JL
Cancer Res; 2002 Feb; 62(3):625-31. PubMed ID: 11830509
[TBL] [Abstract][Full Text] [Related]
5. Bile from a patient with anomalous pancreaticobiliary ductal union promotes the proliferation of human cholangiocarcinoma cells via COX-2 pathway.
Wu GS; Zou SQ; Liu ZR; Wang DY
World J Gastroenterol; 2003 May; 9(5):1094-7. PubMed ID: 12717864
[TBL] [Abstract][Full Text] [Related]
6. Effects of cyclooxygenase-2 antisense vector on proliferation of human cholangiocarcinoma cells.
Wu GS; Zou SQ; Wu XY; Qiu FZ
Chin Med Sci J; 2004 Jun; 19(2):89-92. PubMed ID: 15250241
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib inhibits proliferation and induces apoptosis via cyclooxygenase-2 pathway in human pancreatic carcinoma cells.
Wu G; Yi J; Di F; Zou S; Li X
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(1):42-4. PubMed ID: 15934305
[TBL] [Abstract][Full Text] [Related]
8. Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells.
Kern MA; Schubert D; Sahi D; Schöneweiss MM; Moll I; Haugg AM; Dienes HP; Breuhahn K; Schirmacher P
Hepatology; 2002 Oct; 36(4 Pt 1):885-94. PubMed ID: 12297835
[TBL] [Abstract][Full Text] [Related]
9. Effects of bile from patient with transduodenal sphincteroplasty on the growth of human cholangiocarcinoma cell line.
Wu G; Zou S; Liu Z; Qiu F
Chin Med Sci J; 2004 Mar; 19(1):72. PubMed ID: 15104232
[No Abstract] [Full Text] [Related]
10. Effects of cyclooxygenase 2 inhibitors on biological traits of nasopharyngeal carcinoma cells.
Chen PY; Long QC
Acta Pharmacol Sin; 2004 Jul; 25(7):943-9. PubMed ID: 15210070
[TBL] [Abstract][Full Text] [Related]
11. Involvement of 85-kd cytosolic phospholipase A(2) and cyclooxygenase-2 in the proliferation of human cholangiocarcinoma cells.
Wu T; Han C; Lunz JG; Michalopoulos G; Shelhamer JH; Demetris AJ
Hepatology; 2002 Aug; 36(2):363-73. PubMed ID: 12143044
[TBL] [Abstract][Full Text] [Related]
12. The cyclooxygenase-2 inhibitor celecoxib blocks phosphorylation of Akt and induces apoptosis in human cholangiocarcinoma cells.
Wu T; Leng J; Han C; Demetris AJ
Mol Cancer Ther; 2004 Mar; 3(3):299-307. PubMed ID: 15026550
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation.
Zhang Z; Lai GH; Sirica AE
Hepatology; 2004 Apr; 39(4):1028-37. PubMed ID: 15057907
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells.
Song X; Lin HP; Johnson AJ; Tseng PH; Yang YT; Kulp SK; Chen CS
J Natl Cancer Inst; 2002 Apr; 94(8):585-91. PubMed ID: 11959891
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis.
Leng J; Han C; Demetris AJ; Michalopoulos GK; Wu T
Hepatology; 2003 Sep; 38(3):756-68. PubMed ID: 12939602
[TBL] [Abstract][Full Text] [Related]
18. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
[TBL] [Abstract][Full Text] [Related]
19. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.
Liu X; Yue P; Zhou Z; Khuri FR; Sun SY
J Natl Cancer Inst; 2004 Dec; 96(23):1769-80. PubMed ID: 15572759
[TBL] [Abstract][Full Text] [Related]
20. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]